Cargando…

Optimal therapeutic strategy using antigen‐containing liposomes selectively delivered to antigen‐presenting cells

Recent immunotherapies have shown clinical success. In particular, vaccines based on particulate antigen (Ag) are expected to be implemented based on their efficacy. In the current study, we describe a strategy entailing Ag‐encapsulating PEG‐modified liposomes (PGL‐Ag) as antigen protein delivery de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iyoda, Tomonori, Yamasaki, Satoru, Kawamura, Masami, Ueda, Motoki, Son, Kon, Ito, Yoshihiro, Shimizu, Kanako, Fujii, Shin‐ichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398898/ https://www.ncbi.nlm.nih.gov/pubmed/30629329 http://dx.doi.org/10.1111/cas.13934

Ejemplares similares

Cancer immunotherapy using artificial adjuvant vector cells to deliver NY‐ESO‐1 antigen to dendritic cells in situ
por: Fujii, Shin‐ichiro, et al.
Publicado: (2022)

Association of cellular immunity with severity of COVID-19 from the perspective of antigen-specific memory T cell responses and cross-reactivity
por: Fujii, Shin-ichiro, et al.
Publicado: (2022)

Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer
por: Iyoda, Tomonori, et al.
Publicado: (2023)

Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT Cells
por: Shimizu, Kanako, et al.
Publicado: (2015)

NK and NKT Cell-Mediated Immune Surveillance against Hematological Malignancies
por: Shimizu, Kanako, et al.
Publicado: (2020)

Detection of mutant antigen-specific T cell receptors against multiple myeloma for T cell engineering
por: Okada, Masahiro, et al.
Publicado: (2023)

Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses
por: Fujii, Shin-ichiro, et al.
Publicado: (2018)

In vivo dendritic cell targeting cellular vaccine induces CD4(+) Tfh cell-dependent antibody against influenza virus
por: Yamasaki, Satoru, et al.
Publicado: (2016)

Zeb2 regulates differentiation of long-lived effector of invariant natural killer T cells
por: Iyoda, Tomonori, et al.
Publicado: (2023)

A single immunization with cellular vaccine confers dual protection against SARS‐CoV‐2 and cancer
por: Shimizu, Kanako, et al.
Publicado: (2022)

PD-L1 Expression Affects Neoantigen Presentation
por: Okada, Masahiro, et al.
Publicado: (2020)

Augmenting Granzyme B–Expressing NK Cells by Invariant NKT Ligand–Loaded APCs in Patients with Postoperative Early Stage Non–Small Cell Lung Cancer: Results of a Randomized Phase II Study
por: Iyoda, Tomonori, et al.
Publicado: (2023)

Combination of cancer vaccine with CD122-biased IL-2/anti-IL-2 Ab complex shapes the stem-like effector NK and CD8(+) T cells against tumor
por: Shimizu, Kanako, et al.
Publicado: (2023)

Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFN
por: Shimizu, Kanako, et al.
Publicado: (2019)

Optimization of Liposomes for Antigen Targeting to Splenic CD169(+) Macrophages
por: Nijen Twilhaar, Maarten K., et al.
Publicado: (2020)

Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2
por: Shimizu, Kanako, et al.
Publicado: (2021)

Radiolabelling of Antigen and Liposomes for Vaccine Biodistribution Studies
por: Henriksen-Lacey, Malou, et al.
Publicado: (2010)

Gene therapy of prostate cancer using liposomes containing perforin expression vector driven by the promoter of prostate-specific antigen gene
por: Mizutani, Kosuke, et al.
Publicado: (2022)

Retinoic Acid-Containing Liposomes for the Induction of Antigen-Specific Regulatory T Cells as a Treatment for Autoimmune Diseases
por: ter Braake, Daniëlle, et al.
Publicado: (2021)

Eomes transcription factor is required for the development and differentiation of invariant NKT cells
por: Shimizu, Kanako, et al.
Publicado: (2019)

Licensed liposomal vaccines and adjuvants in the antigen delivery system
por: Krasnopolsky, Yuriy, et al.
Publicado: (2022)

Small Wonders—The Use of Nanoparticles for Delivering Antigen
por: Taki, Aya, et al.
Publicado: (2015)

Direct Expansion of Functional CD25(+) CD4(+) Regulatory T Cells by Antigen-processing Dendritic Cells
por: Yamazaki, Sayuri, et al.
Publicado: (2003)

Pulmonary Delivery of Virosome-Bound Antigen Enhances Antigen-Specific CD4(+) T Cell Proliferation Compared to Liposome-Bound or Soluble Antigen
por: Blom, Rebecca A. M., et al.
Publicado: (2017)

Development of Mannose-Modified Carboxylated Curdlan-Coated Liposomes for Antigen Presenting Cell Targeted Antigen Delivery
por: Yuba, Eiji, et al.
Publicado: (2020)

Establishment of a Human Monoclonal Antibody to Hanganutziu‐Deicher Antigen as a Tumor‐associated Carbohydrate Antigen
por: Usuba, Osamu, et al.
Publicado: (1988)

Association of gross virus-associated cell-surface antigen with liposomes.
por: Sakai, F., et al.
Publicado: (1980)

Effective transcutaneous immunization by antigen-loaded flexible liposome in vivo
por: Li, Ni, et al.
Publicado: (2011)

Liposome-Coupled Antigens Are Internalized by Antigen-Presenting Cells via Pinocytosis and Cross-Presented to CD8(+) T Cells
por: Tanaka, Yuriko, et al.
Publicado: (2010)

Selective tumor antigen vaccine delivery to human CD169(+) antigen-presenting cells using ganglioside-liposomes
por: Affandi, Alsya J., et al.
Publicado: (2020)

Sphingomyelin Liposomes Containing Soluble Leishmania major antigens Induced Strong Th2 Immune Response in BALB/c Mice
por: Chavoshian, Omid, et al.
Publicado: (2013)

Antigen-expressing immunostimulatory liposomes as a genetically programmable synthetic vaccine
por: Amidi, Maryam, et al.
Publicado: (2010)

A Liposome-Based Approach to the Integrated Multi-Component Antigen Microarrays
por: Wang, Denong
Publicado: (2015)

Cationic Liposome Conjugation to Recombinant Adenoviral Vector Reduces Viral Antigenicity
por: Natsume, Atsushi, et al.
Publicado: (2000)

A Malaria Vaccine Adjuvant Based on Recombinant Antigen Binding to Liposomes
por: Huang, Wei-Chiao, et al.
Publicado: (2018)

Design Variation of a Dual-Antigen Liposomal Vaccine Carrier System
por: Nayerhoda, Roozbeh, et al.
Publicado: (2019)

Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens
por: Gao, Jie, et al.
Publicado: (2017)

Cryogenic transmission electron microscopy of recombinant tuberculosis vaccine antigen with anionic liposomes reveals formation of flattened liposomes
por: Fox, Christopher B, et al.
Publicado: (2014)

Ginsan Enhances Humoral Antibody Response to Orally Delivered Antigen
por: Na, Hee Sam, et al.
Publicado: (2010)

Induction of antigen-specific immune tolerance using biodegradable nanoparticles containing antigen and dexamethasone
por: Kim, Sang-Hyun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tdptjd5nhp040crulhc93a0p8d